Icahn, Black Bear to nominate Amylin directors (Reuters)

Reuters – Biotechnology company Amylin Pharmaceuticals Inc on Friday said it was notified of two plans to nominate directors to the company’s board: one by entities associated with investor Carl Icahn and another from shareholder Black Bear Fund I.

Leave a Reply